ArticleCommunications health2026
Forecasting multimorbidity in aging people with HIV using a microsimulation model.
Article in Communications health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: While life expectancy has significantly increased among people living with HIV (PLWH) due to effective antiretroviral therapy, aging-related non-communicable diseases and multimorbidity have emerged as critical challenges. Understanding the evolving health needs of PLWH is essential to guiding healthcare planning and interventions. Methods: We developed a new microsimulation model that integrates longitudinal clinical and administrative data to project the health trajectories of PLWH in British Columbia from 2019 to 2034. High prevalence conditions, such as cardiovascular disease (CVD), non-AIDS-related cancers, chronic liver disease (CLD), hypertension, chronic obstructive pulmonary disease (COPD), and mood and anxiety disorders (MANX), were included in the model. Results were stratified by age and sex. Results: Here we show that by 2034, nearly half of PLWH will be aged 60 years or older, and more than one-quarter will live with at least three additional chronic conditions. CVD is projected to nearly double (8.4-14.8%), cancers to rise from 8.9 to 17.2%, while MANX will remain the most common comorbidity, affecting about half of PLWH. Sex differences are pronounced; females show higher rates of multimorbidity involving MANX, CLD, and COPD, whereas males show higher prevalence of non-AIDS-related cancers and CVD. Conclusions: These findings highlight the urgency of preparing for a sharp increase in multimorbidity and demonstrate the value of forecasting tools to guide integrated models of care for aging PLWH.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.